Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
GLP-1s and reduced cancer risk discovery Using the TriNetX database (a global, multi-institutional platform of de-identified patient data), Jones and his team were among the first to identify a strong association between GLP-1 medications, commonly used for diabetes and weight loss, and a significant reduction in cancer risk
PMID 19640223
Second, several states expanded Medicaid coverage to include GLP-1s specifically approved for obesity, such as Wegovy and Zepbound
The Month 2 dose increase is data-driven, not arbitrary
US$ 25.29
US$ 21.10
US$ 29.77
US$ 20.38
